Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working GroupAntonio Palumbo, Philippe Moreau, Andrew Spencer et al.|Journal of Clinical Oncology|2015Cited by 2.2k
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerHarry Bleiberg, Tarek Sahmoud, Thierry Conroy et al.|European Journal of Cancer|1997Cited by 347
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patientsFrancesca Gay, Antonio Palumbo, Alessandra Larocca et al.|Blood|2011Cited by 268
Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated resultsFrancesca Gay, Antonio Palumbo, Valeria Magarotto et al.|Blood|2013Cited by 82
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomibManuela Gambella, Antonio Palumbo, Alberto Rocci et al.|Haematologica|2014Cited by 56